Roche Diagnostics said today that it has signed a license agreement with Takara Bio of Shiga, Japan, that gives Takara the right to use melting curve analysis technology and SYBR Green techniques in kits and instruments for real-time PCR.
Specifically, the agreement gives Takara a non-exclusive license for the use of the technology with instruments in Japan, and for worldwide use in kits, in the field of research applications.
Financial terms of the agreement were not disclosed.
The agreement covers reagents and/or methods using SYBR Green I technology and melting curve analysis for real-time PCR. The technologies are part of an intellectual property portfolio maintained by Roche in cooperation with Idaho Technology.
The agreement follows a licensing agreement for the SYBR Green and melting curve analysis technology that Idaho Technologies announced earlier this week with Kapa Biosystems.